NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma

Name: NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma
License: Public Domain

Nektar Therapeutics

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non

non-hodgkin lymphoma, relapsed/refractory diffuse large b-cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 432883
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.